Table 2.
Subj | Age | Gender | Age HL onset (in years) |
Processor/ HA |
Years of CI Use |
CI Ear/ Device |
Strategy | # Active Channels/ # Available Channels |
Frequency Allocation in Hz |
Etiology of Deafness |
---|---|---|---|---|---|---|---|---|---|---|
2 | 68 | M | 27 | Tempo+Duet/Widex | 5 | L/MED-EL Pulsar EAS | CIS | 10/12 | 500–8500 | Unknown |
3 | 67 | M | 21 | Tempo+Duet/Phonak | 1 | R/ME Sonata EAS Flex | CIS | 10/12 | 500–8500 | Noise Exposure |
4 | 39 | F | 14 | Tempo+Duet/Tempo+Duet | 1 | R/ME Pulsar EAS Flex | CIS | 12/12 | 300–8500 | Unknown |
5 | 79 | M | 40 | Freedom/Phonak | 2 | R/CA Hybrid L24 | ACE | 18/24 | 1188–7938 | Hereditary |
6 | 55 | F | 40 | Freedom/Phonak | 2 | R/CA Hybrid L24 | ACE | 18/24 | 1188–7938 | Unknown |
7 | 70 | M | 42 | Freedom/Widex | 1.6 | L/CA Hybrid L24 | ACE | 18/24 | 1188–7938 | Hereditary |
8 | 64 | M | 20 | Opus 2 Duet/Danalogics | 6 | L/ME Pulsar Medium | FSP | 10/12 | 690–8500 | Hereditary |
9 | 69 | F | 47 | Opus 2/Phonak | 1 | R/ME Sonata Flex | FSP | 10/12 | 100–8000 | Hereditary |
10 | 47 | F | 32 | Freedom/Phonak | 3 | R/CA Hybrid L24 | ACE | 18/24 | 1188–7938 | Unknown |
11 | 35 | M | 5 | Opus 2/Unaided | 2 | L/ME Sonata Medium | FSP | 11/12 | 332–7500 | Unknown |
12 | 50 | F | 32 | Freedom/Phonak | 3 | R/CA Hybrid L24 | MP12 | 20/24 | 1188–7938 | Hereditary |
13 | 62 | F | 52 | Tempo+Duet/Phonak | 2 | L/ME Sonata EAS Flex | CIS | 12/12 | 500–8500 | Viral Infection |
ME = MED-EL. CC = Cochlear Corp.